PETALUMA, Calif., Oct. 10, 2017 -- Calix, Inc. (NYSE:CALX), the world leader in Subscriber Driven Intelligent Access, today announced that the company will report third quarter fiscal year 2017 results on Tuesday, November 7th after the market closes. Calix will host a conference call to discuss these results at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on the same day.
Interested parties can listen to a live webcast of the conference call by visiting the Calix Investor Relations website at http://investor-relations.calix.com/. The conference call is also available via teleconference by dialing (877) 407-4019 or international (201) 689-8337 with conference ID#13658618. The conference call and webcast will include forward-looking information.
A replay of the conference call will also be available at http://investor-relations.calix.com/ following the completion of the call. The call will be archived at http://investor-relations.calix.com/.
Upcoming Investor Conference Participation
Calix, Inc. today also announced management will participate in the following investor conference during the fourth quarter of fiscal year 2017:
- Cowen Networking & Cybersecurity Summit on December 12th in New York, NY
Details for this event are available in the Events & Presentations section at http://investor-relations.calix.com/.
About Calix
Calix, Inc. (NYSE:CALX) pioneered Software Defined Access and cloud products focused on access networks and the subscriber. Its portfolio of Intelligent Access systems and software combines AXOS, the revolutionary platform for access, with Calix Cloud, innovative cloud products for network data analytics and subscriber experience assurance. Together, they enable communications service providers to transform their businesses and be the winning service providers of tomorrow. For more information, visit the Calix website at www.calix.com.
Investor Inquiries:
Thomas J. Dinges, CFA
Director of Investor Relations
408-474-0080
[email protected]


Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 



